Blog
Form 8.3 - The Vanguard Group, Inc.: Brewin Dolphin Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Brewin Dolphin Holdings plc
DGAP-News: Francotyp-Postalia Holding AG: FP Annual General Meeting with outlook of further transformation with profitable growth
DGAP-News: Francotyp-Postalia Holding AG: FP Annual General Meeting with outlook of further transformation with profitable growth
Fix Price Group Ltd. : Notification of PDMR transaction
Fix Price Group Ltd. : Notification of PDMR transaction
Nordea Bank Abp: Nordea completes follow-on share buy-back
Nordea Bank Abp: Nordea completes follow-on share buy-back
DGAP-News: Hawesko Holding AG: Annual General Meeting approves payment of a dividend of € 2.50 per share
DGAP-News: Hawesko Holding AG: Annual General Meeting approves payment of a dividend of € 2.50 per share
DGAP-News: CEWE: Thirteenth Consecutive Dividend Increase
DGAP-News: CEWE: Thirteenth Consecutive Dividend Increase
Travis Perkins: TR1 Notification of Major Share Interest
Travis Perkins: TR1 Notification of Major Share Interest
DGAP-Adhoc: CLIQ Digital raises sales and earnings guidance for 2022
DGAP-Adhoc: CLIQ Digital raises sales and earnings guidance for 2022
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
DGAP-Adhoc: Südzucker significantly raises forecast for EBITDA and operating result for fiscal 2022/23
DGAP-Adhoc: Südzucker significantly raises forecast for EBITDA and operating result for fiscal 2022/23
DGAP-Adhoc: Allterco JSCo provides American subsidiary Allterco Robotics U.S. with additional financing
DGAP-Adhoc: Allterco JSCo provides American subsidiary Allterco Robotics U.S. with additional financing
'Sparadies' on sixt-neuwagen.de: Attractive special discounts on selected vehicles
'Sparadies' on sixt-neuwagen.de: Attractive special discounts on selected vehicles
DGAP-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse invests in connectivity and digitalization expertise by acquiring majority stake in Spanish company Cojali S.L. in a move that will also boost its afterma
DGAP-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse invests in connectivity and digitalization expertise by acquiring majority stake in Spanish company Cojali S.L. in a move that will also boost its afterma
DGAP-News: Successful alliance: EasyMotionSkin starts development partnership with international automobile manufacturer
DGAP-News: Successful alliance: EasyMotionSkin starts development partnership with international automobile manufacturer
u-blox AG: u-blox launches world’s smallest GPS module
u-blox AG: u-blox launches world’s smallest GPS module
Media release: Shorter delivery times for high-precision humidity and temperature sensors
Media release: Shorter delivery times for high-precision humidity and temperature sensors
DGAP-News: beaconsmind AG: beaconsmind AG: Hauck & Aufhäuser Lampe Privatbank AG continues to rate beaconsmind share as 'Buy' – Price target EUR 30.00
DGAP-News: beaconsmind AG: beaconsmind AG: Hauck & Aufhäuser Lampe Privatbank AG continues to rate beaconsmind share as 'Buy' – Price target EUR 30.00
DGAP-News: Multitude SE extends its FinTech Growth Platform Strategy to external parties
DGAP-News: Multitude SE extends its FinTech Growth Platform Strategy to external parties
DGAP-Adhoc: AURELIUS Equity Opportunities SE & Co. KGaA resolves retirement of 1,000,000 treasury shares
DGAP-Adhoc: AURELIUS Equity Opportunities SE & Co. KGaA resolves retirement of 1,000,000 treasury shares
DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Q1 2022 Financial Results and Highlights Operational Progress
DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Q1 2022 Financial Results and Highlights Operational Progress
DGAP-News: MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210
DGAP-News: MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210